Advertisement
Advertisement
RNAC
Cartesian Therapeutics, Inc. Common Stock
6.89
USDSponsored
-0.13
-1.85%
Nov 10, 15:59 UTC -5
Closed
After-Market
6.88
0.00
-0.07%
Cartesian Therapeutics, Inc. Common Stock (RNAC)
Cartesian Therapeutics, Inc. Common Stock Financial Snapshot
| Market Cap | 210.01M |
| Beta | 0.74 |
| Earnings Per Share (EPS) | -4.94 |
| Price-to-Book (P/B) Ratio | -- |
| Operating Margin | -5356.28% |
| Total Debt/Equity (D/E) | -38.49% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -- |
| Current Ratio | 8.38% |
| Free Cash Flow | -71.69M |
